Adipong Brickshawana is a Cardiology physician. OpenAlex indexes 10 publications with 611 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
111 Colchester Ave
Burlington, VT 054011473
Telephone
802-847-4600Provider last certified this registry record 7 Apr 2025.
Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year202529 payments$30,275openpaymentsdata.cms.gov ↗
- Edwards Lifesciences CorporationProgram year202517 payments
- Boston Scientific CorporationProgram year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2020)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
51.5%Statin22.5%Atorvastatin Calcium71%Simvastatin29%Part D<11 patientsCalcium channel blocker10%Amlodipine Besylate51%Nifedipine Er49%Part D<11 patients+ 4 more classes in this area
Metabolism & gastrointestinal
28.4%DPP-4 inhibitor7.4%Januvia63%Janumet37%Part D<11 patientsBiguanide (metformin)6.4%Metformin Hcl Er54%Metformin Hcl46%Part D<11 patients+ 3 more classes in this area
Respiratory
8.1%beta2-Adrenergic Agonist4.4%Albuterol Sulfate Hfa100%Part D<11 patientsCorticosteroid3.7%Fluticasone Propionate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Sex-based utilization of guideline recommended statin therapy and cardiovascular disease outcomes: Data from a multisite healthcare network primary prevention cohort
American Journal of Preventive Cardiology
2024 - The Functional Heterogeneity of Resident Cardiac Macrophages in Myocardial Injury
Circulation Research
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”